Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zohar Argov

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|July 9, 2014
GNE myopathy: current update and future therapyIchizo Nishino, Nuria Carrillo-Carrasco, Zohar Argov
Journal of the Neurological Sciences|April 10, 2012
Myasthenia gravis appearing 18 years after resection of benign thymoma with subsequent limbic encephalitisAdir Shaulov, Misgav Rottenstreich, Hagit Peleg, et al.
American Journal of Medical Genetics|November 20, 2002
Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletionIsabelle Korn-Lubetzki, Zohar Argov, Annick Raas-Rothschild, et al.
Biomed Research International|March 21, 2015
Corrigendum to "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice"Marc Gotkine, Leah Rozenstein, Ofira Einstein, et al.
Neurology. Genetics|March 8, 2019
<i>GNE</i> genotype explains 20% of phenotypic variability in GNE myopathyOksana Pogoryelova, Ian J Wilson, Hank Mansbach, et al.
Dysphagia|May 5, 2018
A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD)Ashley A Waito, Catriona M Steele, Melanie Peladeau-Pigeon, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Antisense treatment for myasthenia gravis: experience with monarsenJon D Sussman, Zohar Argov, David McKee, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Further developments with antisense treatment for myasthenia gravisJon Sussman, Zohar Argov, Yitzhak Wirguin, et al.
Journal of Neuromuscular Diseases|November 22, 2021
Pre Clinical Assessment of AAVrh74.MCK.GNE Viral Vector Therapeutic Potential: Robust Activity Despite Lack of Consistent Animal Model for GNE MyopathyStella Mitrani-Rosenbaum, Lena Yakovlev, Michal Becker Cohen, et al.
Journal of the Neurological Sciences|July 2, 2005
Extrathymic malignancies in patients with myasthenia gravisNetta Levin, Oded Abramsky, Alexander Lossos, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Journal of Neurology, Neurosurgery, and Psychiatry|July 9, 2014
GNE myopathy: current update and future therapyIchizo Nishino, Nuria Carrillo-Carrasco, Zohar Argov
Journal of the Neurological Sciences|April 10, 2012
Myasthenia gravis appearing 18 years after resection of benign thymoma with subsequent limbic encephalitisAdir Shaulov, Misgav Rottenstreich, Hagit Peleg, et al.
American Journal of Medical Genetics|November 20, 2002
Family with inflammatory demyelinating polyneuropathy and the HNPP 17p12 deletionIsabelle Korn-Lubetzki, Zohar Argov, Annick Raas-Rothschild, et al.
Biomed Research International|March 21, 2015
Corrigendum to "Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice"Marc Gotkine, Leah Rozenstein, Ofira Einstein, et al.
Neurology. Genetics|March 8, 2019
<i>GNE</i> genotype explains 20% of phenotypic variability in GNE myopathyOksana Pogoryelova, Ian J Wilson, Hank Mansbach, et al.
Dysphagia|May 5, 2018
A Preliminary Videofluoroscopic Investigation of Swallowing Physiology and Function in Individuals with Oculopharyngeal Muscular Dystrophy (OPMD)Ashley A Waito, Catriona M Steele, Melanie Peladeau-Pigeon, et al.
Annals of the New York Academy of Sciences|June 24, 2008
Antisense treatment for myasthenia gravis: experience with monarsenJon D Sussman, Zohar Argov, David McKee, et al.
Annals of the New York Academy of Sciences|January 3, 2013
Further developments with antisense treatment for myasthenia gravisJon Sussman, Zohar Argov, Yitzhak Wirguin, et al.
Journal of Neuromuscular Diseases|November 22, 2021
Pre Clinical Assessment of AAVrh74.MCK.GNE Viral Vector Therapeutic Potential: Robust Activity Despite Lack of Consistent Animal Model for GNE MyopathyStella Mitrani-Rosenbaum, Lena Yakovlev, Michal Becker Cohen, et al.
Journal of the Neurological Sciences|July 2, 2005
Extrathymic malignancies in patients with myasthenia gravisNetta Levin, Oded Abramsky, Alexander Lossos, et al.
Pageof 6